RNA-targeted therapeutics · BEGINNER LESSON
Antisense oligonucleotide (ASO)
An antisense oligonucleotide (ASO) is a short, synthetic nucleic acid that binds a matching RNA sequence by base pairing. It is measured by its sequence, length, chemical design, and ability to change RNA fate such as cleavage, splicing, translation, or stability.
What ASOs are
Antisense oligonucleotides are short, synthetic nucleic acid polymers that act at the RNA level, not by adding a new gene copy. They are usually about 18–30 nucleotides long, and their key feature is sequence complementarity: the ASO is designed to match a target RNA sequence. A nucleotide is one building block of nucleic acids such as DNA and RNA. A complementary sequence is one that can pair through Watson-Crick base pairing, the standard matching rule between RNA bases. [0,1,2]
[1] The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery [2] 3. Antisense Oligonucleotide... [3] The Versatile Applications of Antisense Oligonucleotides in Modern Medicine
How they work
ASOs can act in several ways. Some designs recruit RNase H, a cellular enzyme that cuts the RNA in a DNA–RNA duplex, which lowers the amount of target transcript and protein. Other ASOs are steric blockers: they sit on RNA and physically block ribosomes, splicing factors, or signals that control polyadenylation, which can change translation or pre-mRNA splicing. Splicing is the process that edits pre-mRNA, a newly made RNA copy, before it becomes mature RNA. [0,1,2]
[1] The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery [2] 3. Antisense Oligonucleotide... [3] The Versatile Applications of Antisense Oligonucleotides in Modern Medicine
Where they are used
Because ASOs act on RNA, they can help in disorders caused by too much harmful RNA activity or by missing functional protein. Examples in the sources include exon skipping to restore the reading frame in Duchenne muscular dystrophy and other splice-modulating strategies that can increase production of a useful protein. The reading frame is the way RNA letters are grouped into protein-coding units. [0,1,2]
[1] The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery [2] 3. Antisense Oligonucleotide... [3] The Versatile Applications of Antisense Oligonucleotides in Modern Medicine
Limits and challenges
ASOs do not usually change the genome, so their effects fade as the molecules are broken down or diluted during cell turnover; many treatments need repeated dosing. Delivery is also difficult because ASOs do not cross cell membranes or body barriers easily, and reaching tissues outside the liver remains a major challenge. Safety issues include off-target binding, thrombocytopenia, renal accumulation, and injection-site reactions. [0,1,2]
[1] The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery [2] 3. Antisense Oligonucleotide... [3] The Versatile Applications of Antisense Oligonucleotides in Modern Medicine
SEE THE IDEA
How an ASO changes RNA behavior
A short synthetic ASO is made to match one target RNA sequence.
The ASO pairs with the RNA by complementary base pairing.
RNase H can recognize the duplex and cleave the RNA strand.
Or the ASO can physically block splicing or translation machinery.
Less protein, more correct protein, or altered RNA processing can result.
A sequence-matched ASO binds RNA and then either triggers RNA cleavage or blocks RNA processing steps.
ASOs work by binding RNA first, then changing what cellular machinery can do with that RNA.
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.